NEX-I

Nex-i.com is the premier digital marketing solutions, website development and technology service provider for the small business. Nex-i.com delivers its state-of-the-art, turnkey Internet, digital marketing solutions and consultations, directly to the desktop computers of small businesses in suburban markets and secondary cities. Focussing only in vegan business friendly market, Nex-i.com is the first pioneer in Indonesia to educate society about veganism and environmental issue.
NEX-I
Industry:
Small And Medium Businesses
Founded:
1999-01-01
Address:
Jakarta, Jakarta Raya, Indonesia
Country:
Indonesia
Website Url:
http://www.nex-i.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
22 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Investors List
LLR Partners
LLR Partners investment in Series B - Nex-i
Updata Ventures Partners
Updata Ventures Partners investment in Series B - Nex-i
Mellon Ventures
Mellon Ventures investment in Series B - Nex-i
Resolution Capital Limited
Resolution Capital Limited investment in Series B - Nex-i
Liberty Venture Partners
Liberty Venture Partners investment in Series B - Nex-i
Coqui Capital Partners
Coqui Capital Partners investment in Series B - Nex-i
Official Site Inspections
http://www.nex-i.com
- Host name: srv170.niagahoster.com
- IP address: 153.92.13.30
- Location: Indonesia
- Latitude: -6.175
- Longitude: 106.8286
- Timezone: Asia/Jakarta

More informations about "Nex-i"
Nex-i - Crunchbase Company Profile & Funding
Nex-i.com delivers its state-of-the-art, turnkey Internet, digital marketing solutions and consultations, directly to the desktop computers of small businesses in suburban markets and โฆSee details»
Nex-I.com Inc - Company Profile and News - Bloomberg Markets
Nex-I.com Inc. provides technology services for the small business. The Company delivers its state-of-the-art, turnkeySee turnkey system, internet, and network and data solutions directly to...See details»
NEX-I Company Profile 2024: Valuation, Funding & Investors
Developer of next-generation Immunotherapeutics designed to induce cancer cells to become refractory to the current treatment.See details»
Nex-i (Database Software) - PitchBook
Provider of networking tools for small businesses. The company's networking tools offers turnkey Internet, network and data services directly to the desktop computers of small businesses in โฆSee details»
Nex-i - Funding, Financials, Valuation & Investors - Crunchbase
Nex-i.com, a digital marketing solutions provider for small businesses in Jakarta, Bandung, Bali, IndonesiaSee details»
Ono Enters into a License Agreement with NEX-I to Develop and ...
Mar 6, 2024ย ยท Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO, Gyo Sagara; โOnoโ) today announced that it has entered into a license agreement with NEX-I, Inc. (Seoul, โฆSee details»
Ono signs licence deal with NEX-I for cancer therapy
Mar 6, 2024ย ยท Ono Pharmaceutical has signed an exclusive licence agreement for the development and marketing of NEX-Iโs new cancer therapy, NXI-101. An antibody drug โฆSee details»
Nex-i - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nex-i.com, a digital marketing solutions provider for small businesses in Jakarta, Bandung, Bali, IndonesiaSee details»
NEX-I Stock Price, Funding, Valuation, Revenue & Financial โฆ
Oct 7, 2022ย ยท See NEX-I funding rounds, investors, investments, exits and more. Evaluate their financials based on NEX-I's post-money valuation and revenue.See details»
Ono Pharma inks licensing agreement with NEX-I to develop and ...
Mar 7, 2024ย ยท Ono Pharmaceutical Co., Ltd., company develops novel therapeutics to help patients live longer, healthier lives, announced that it has entered into a license agreement โฆSee details»
NEX-I, Inc. Company Profile | Seoul, Seoul, Republic Of Korea ...
Find company research, competitor information, contact details & financial data for NEX-I, Inc. of Seoul, Seoul. Get the latest business insights from Dun & Bradstreet.See details»
NEX -I - VentureRadar
NEX-I is a trailblazer in the field of cancer immunotherapy, dedicated to confronting the challenges posed by cancer. Leveraging an advanced biotechnology platform and a team of โฆSee details»
NEX-I - Products, Competitors, Financials, Employees, โฆ
NEX-I is a biotechnology company focused on developing next-generation immunotherapies for cancer treatment. The company specializes in creating therapies that target resistant โฆSee details»
NEX-I | BIO-Europe - Informa Connect
NEX-I is a pioneering team in the realm of immuno-oncology, taking innovative footsteps to challenge and transform current cancer treatment methods. At the heart of its cutting-edge โฆSee details»
A case study on Nex-I - YouTube
Weโre excited to share a recent success story with NEX-I, a valued client of 3DforScience! Theyโve used our video across their website, investor relations, and key presentations, โฆSee details»
National League for Nursing - Proctor360
Proctor360 is a proud member of organizations dedicated to online learning and testing excellence.See details»
NEX-I
NEX-I stands at the pinnacle of biotech advancements, steering a transformative path in cancer immunotherapy. With a globally recognized specialist team, we've crafted an avant-garde โฆSee details»
Committed to Advancing the Understanding of Immunotherapy โฆ
NEX-I is a pioneering biotech headquartered in South Korea, specializing in next-generation cancer therapies with a focus on immunotherapy-resistant cancers.See details»
Death of Nex Benedict - Wikipedia
Nex Benedict (January 11, 2008 โ February 8, 2024) [1] was a 16-year-old non-binary American high school student who died the day after a physical altercation in the girls' restroom of their โฆSee details»
NEXT Canada - Building a more ambitious and competitive Canada
Aug 12, 2011ย ยท NEXT Canada accelerates the growth trajectory of aspiring and scaling entrepreneurs with education, mentorship, funding and access to Canada's strongest โฆSee details»